Elsevier launches Photodiagnosis and Photodynamic Therapy
First issue of new journal to publish in June 2004.
Amsterdam, 7 June 2004 – Elsevier has launched a new journal, Photodiagnosis and Photodynamic Therapy, dedicated to disseminating scientific knowledge and clinical developments in photodiagnosis (PD) and photodynamic therapy (PDT) for all medical specialties. The first issue of this international, peer-reviewed journal will be published in early June 2004.
PDT emerged into the clinical area in the late 1970s, but until now, there has been no journal that focused exclusively on the subject. Previously, papers and information on PDT were scattered among many different journals and specialties. Now, with more than 10,000 publications on this topic, PDT and its genetically related partner PD, have a new place to call home with the launch of Elsevier’s new journal. Published quarterly, Photodiagnosis and Photodynamic Therapy will contain original articles, reviews, case presentations, "how-to" pieces, letters to the editor, short communications, and images with short descriptions.
Professor K. Moghissi, Consultant Cardiothoracic Surgeon, and Clinical Director of the Yorkshire Laser Centre, will lead the journal’s editorial board. He commented:
“With this first issue of Photodiagnosis and Photodynamic Therapy, we witness the birth of a publication which we hope will be interesting, informative and useful both to those clinicians already familiar with the techniques and to those who wish to begin using them. I see the responsibility of the journal as bringing together research, experimental work and clinical application.”
“It is a privilege to be the first Editor of Photodiagnosis and Photodynamic Therapy and my hope is that this journal will prove to be a voice for PDT and PD and carry their practices and advances across geographical frontiers, in order to remove barriers of misunderstanding and ignorance.”
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. www.elsevier.com